Safi Biotherapeutics Secures $4.7M to Advance Clinical Trials of Red Blood Cells#United_States#Cambridge#Clinical_Trial#Red_Blood_Cells#Safi_Biotherapeutics
Safi Biotherapeutics Secures $4.7M to Advance Clinical Trials of Red Blood Cells
Safi Biotherapeutics has been awarded a $4.7 million extension from the U.S. DoW to further develop manufactured red blood cells for clinical trials by 2027.
third-news.com
November 3, 2026 at 1:31 PM
Safi Biotherapeutics Secures $4.7M to Advance Clinical Trials of Red Blood Cells#United_States#Cambridge#Clinical_Trial#Red_Blood_Cells#Safi_Biotherapeutics
Innovative Partnership Between Safi Biotherapeutics and DesiCorp to Freeze-Dry Blood Cells#United_States#Cambridge#Red_Blood_Cells#Safi_Biotherapeutics#DesiCorp
Innovative Partnership Between Safi Biotherapeutics and DesiCorp to Freeze-Dry Blood Cells
Safi Biotherapeutics and DesiCorp have partnered to freeze-dry manufactured red blood cells, enhancing access to life-saving blood products in emergencies.
third-news.com
March 31, 2026 at 12:24 PM
Innovative Partnership Between Safi Biotherapeutics and DesiCorp to Freeze-Dry Blood Cells#United_States#Cambridge#Red_Blood_Cells#Safi_Biotherapeutics#DesiCorp
Safi Biotherapeutics and ARMI Achieve Major Milestone in RBC Production Innovation#United_States#Cambridge#Safi_Biotherapeutics#ARMI_BioFabUSA#mRBC_Production
Safi Biotherapeutics and ARMI Achieve Major Milestone in RBC Production Innovation
Safi Biotherapeutics and ARMI | BioFabUSA successfully transfer a 10L mRBC production system, advancing clinical-scale blood cell manufacturing for transfusions.
third-news.com
January 8, 2026 at 1:16 PM
Safi Biotherapeutics and ARMI Achieve Major Milestone in RBC Production Innovation#United_States#Cambridge#Safi_Biotherapeutics#ARMI_BioFabUSA#mRBC_Production
Safi Biotherapeutics and Functional Fluidics Join Forces to Enhance the Quality of Manufactured Red Blood Cells#USA#Cambridge,_Massachusetts#Safi_Biotherapeutics#Functional_Fluidics#mRBCs
Safi Biotherapeutics and Functional Fluidics Join Forces to Enhance the Quality of Manufactured Red Blood Cells
Safi Biotherapeutics collaborates with Functional Fluidics to ensure the health and quality of manufactured red blood cells for sickle cell disease treatment.
third-news.com
July 16, 2025 at 11:08 AM
Safi Biotherapeutics and Functional Fluidics Join Forces to Enhance the Quality of Manufactured Red Blood Cells#USA#Cambridge,_Massachusetts#Safi_Biotherapeutics#Functional_Fluidics#mRBCs